These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36539999)

  • 1. Opening the amino acid toolbox for peptide-based NTS2-selective ligands as promising lead compounds for pain management.
    Previti S; Desgagné M; Tourwé D; Cavelier F; Sarret P; Ballet S
    J Pept Sci; 2023 Jun; 29(6):e3471. PubMed ID: 36539999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotensin Analogues Containing Cyclic Surrogates of Tyrosine at Position 11 Improve NTS2 Selectivity Leading to Analgesia without Hypotension and Hypothermia.
    Eiselt E; Gonzalez S; Martin C; Chartier M; Betti C; Longpré JM; Cavelier F; Tourwé D; Gendron L; Ballet S; Sarret P
    ACS Chem Neurosci; 2019 Nov; 10(11):4535-4544. PubMed ID: 31589400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamic and pharmacokinetic profiles of a neurotensin receptor type 2 (NTS2) analgesic macrocyclic analog.
    Chartier M; Desgagné M; Sousbie M; Rumsby C; Chevillard L; Théroux L; Haroune L; Côté J; Longpré JM; Boudreault PL; Marsault É; Sarret P
    Biomed Pharmacother; 2021 Sep; 141():111861. PubMed ID: 34229249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimized Opioid-Neurotensin Multitarget Peptides: From Design to Structure-Activity Relationship Studies.
    Gonzalez S; Dumitrascuta M; Eiselt E; Louis S; Kunze L; Blasiol A; Vivancos M; Previti S; Dewolf E; Martin C; Tourwé D; Cavelier F; Gendron L; Sarret P; Spetea M; Ballet S
    J Med Chem; 2020 Nov; 63(21):12929-12941. PubMed ID: 32902268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Molecular Modeling to Design Selective NTS2 Neurotensin Analogues.
    Fanelli R; Floquet N; Besserer-Offroy É; Delort B; Vivancos M; Longpré JM; Renault P; Martinez J; Sarret P; Cavelier F
    J Med Chem; 2017 Apr; 60(8):3303-3313. PubMed ID: 28368584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, Structural Optimization, and Characterization of the First Selective Macrocyclic Neurotensin Receptor Type 2 Non-opioid Analgesic.
    Chartier M; Desgagné M; Sousbie M; Côté J; Longpré JM; Marsault E; Sarret P
    J Med Chem; 2021 Feb; 64(4):2110-2124. PubMed ID: 33538583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NTS1 and NTS2 mediate analgesia following neurotensin analog treatment in a mouse model for visceral pain.
    Smith KE; Boules M; Williams K; Richelson E
    Behav Brain Res; 2012 Jun; 232(1):93-7. PubMed ID: 22504145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for a role of NTS2 receptors in the modulation of tonic pain sensitivity.
    Roussy G; Dansereau MA; Baudisson S; Ezzoubaa F; Belleville K; Beaudet N; Martinez J; Richelson E; Sarret P
    Mol Pain; 2009 Jul; 5():38. PubMed ID: 19580660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a metabolically stable neurotensin receptor 2 (NTS2) ligand.
    Held C; Plomer M; Hübner H; Meltretter J; Pischetsrieder M; Gmeiner P
    ChemMedChem; 2013 Jan; 8(1):75-81. PubMed ID: 23097347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pain relief devoid of opioid side effects following central action of a silylated neurotensin analog.
    Tétreault P; Besserer-Offroy É; Brouillette RL; René A; Murza A; Fanelli R; Kirby K; Parent AJ; Dubuc I; Beaudet N; Côté J; Longpré JM; Martinez J; Cavelier F; Sarret P
    Eur J Pharmacol; 2020 Sep; 882():173174. PubMed ID: 32534076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based evolution of subtype-selective neurotensin receptor ligands.
    Schaab C; Kling RC; Einsiedel J; Hübner H; Clark T; Seebach D; Gmeiner P
    ChemistryOpen; 2014 Oct; 3(5):206-18. PubMed ID: 25478316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NTS2-selective neurotensin mimetics with tetrahydrofuran amino acids.
    Simeth NA; Bause M; Dobmeier M; Kling RC; Lachmann D; Hübner H; Einsiedel J; Gmeiner P; König B
    Bioorg Med Chem; 2017 Jan; 25(1):350-359. PubMed ID: 27842797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolically stable neurotensin analogs exert potent and long-acting analgesia without hypothermia.
    Vivancos M; Fanelli R; Besserer-Offroy É; Beaulieu S; Chartier M; Resua-Rojas M; Mona CE; Previti S; Rémond E; Longpré JM; Cavelier F; Sarret P
    Behav Brain Res; 2021 May; 405():113189. PubMed ID: 33607165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of NTS2 receptors in stress-induced analgesia.
    Lafrance M; Roussy G; Belleville K; Maeno H; Beaudet N; Wada K; Sarret P
    Neuroscience; 2010 Mar; 166(2):639-52. PubMed ID: 20035838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotensin(8-13) analogs as dual NTS1 and NTS2 receptor ligands with enhanced effects on a mouse model of Parkinson's disease.
    Kühl T; Georgieva MG; Hübner H; Lazarova M; Vogel M; Haas B; Peeva MI; Balacheva AA; Bogdanov IP; Milella L; Ponticelli M; Garev T; Faraone I; Detcheva R; Minchev B; Petkova-Kirova P; Tancheva L; Kalfin R; Atanasov AG; Antonov L; Pajpanova TI; Kirilov K; Gastreich M; Gmeiner P; Imhof D; Tzvetkov NT
    Eur J Med Chem; 2023 Jun; 254():115386. PubMed ID: 37094450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of Macrocyclic Neurotensin Receptor Type 2 (NTS2) Opioid-Free Analgesics.
    Desgagné M; Chartier M; Lagard C; Ferková S; Choquette M; Longpré JM; Côté J; Boudreault PL; Sarret P
    Angew Chem Int Ed Engl; 2024 Aug; ():e202405941. PubMed ID: 39110923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurotensin modulates the electrical activity of frog pituitary melanotropes via activation of a G-protein-coupled receptor pharmacologically related to both the NTS1 and nts2 receptors of mammals.
    Belmeguenai A; Vaudry H; Leprince J; Vivet B; Cavelier F; Martinez J; Louiset E
    Neuroendocrinology; 2000 Dec; 72(6):379-91. PubMed ID: 11146421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the proline residue on ligand binding of neurotensin receptor 2 (NTS2)-selective peptide-peptoid hybrids.
    Held C; Hübner H; Kling R; Nagel YA; Wennemers H; Gmeiner P
    ChemMedChem; 2013 May; 8(5):772-8. PubMed ID: 23532897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between NTS2 neurotensin and opioid receptors on two nociceptive responses assessed on the hot plate test in mice.
    Bredeloux P; Costentin J; Dubuc I
    Behav Brain Res; 2006 Dec; 175(2):399-407. PubMed ID: 17074405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NT69L, a novel analgesic, shows synergy with morphine.
    Boules M; Shaw A; Liang Y; Barbut D; Richelson E
    Brain Res; 2009 Oct; 1294():22-8. PubMed ID: 19651107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.